Login
Navigate Fool.com
Will VRTX beat
the market?

Vertex Pharmaceuticals (NASDAQ: VRTX)

Community Rating: 3 Stars: Appealing

95.77 -2.37 (-2.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $97.87
Previous Close $98.14
Daily Range $95.68 - $98.45
52-Week Range $58.06 - $99.74
Market Cap $22.6B
P/E Ratio -63.32
Dividend (Yield) $0.00 (0.0%)
Volume 1,951,030
Average Daily Volume 2,940,255
Current FY EPS -$2.67

How do you think VRTX
will perform against the market?

Top VRTX Bull/Bear Pitches

 

chris293 (< 20)
Submitted February 28, 2013

Vertex is on the leading edge for new cures of many dieases and inflections. Maybe the year of stocks ending with an 'x' is back. Micro-cures could be the answers to what ails us.

0 Replies Reply Report this Post
 

georacer (0)
Submitted July 21, 2011

Vertex's blockbuster drug Telaprevir, which is used for the treatment of Hepatitis C has a 1 in 3 chance of causing a scarring rash that is so bad that treatment must be stopped. Another drug that has … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Up 33%: Is Vertex Pharmaceuticals Stock Overpriced?

Read below for more on this stock, which has climbed so much year-to-date and seems to potentially be priced to perfection.

Fed: Beware of social media, biotech stocks

Nasdaq 100 Movers: VRTX, MYL

3 Stocks to Get on Your Watchlist

Two foreign automakers that could drive over the competition and a behemoth biotech whose valuation may deflate are this week's must-watch stocks.

Merck, Gilead Lead Race To Eradicate Hepatitis C

Time to Buy Vertex Pharmaceuticals Inc?

Vertex's cystic fibrosis franchise is just getting started.

40% Pop: Is this Ground Breaking Biotech Still a Buy?

Vertex soared last week on CF data, but have investors missed the boat?

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains.

This Week in Biotech: MannKind's "Finally" Moment and Vertex's Breathtaking Data

MannKind receives favorable news from the FDA while Vertex stuns investors. Plus, three additional biotech companies deliver encouraging clinical results.

Why Vertex Pharmaceuticals, Integrys Energy Group, and Iron Mountain Soared Last Week

These stocks led the S&P 500 higher.

See More VRTX News...

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks